Business
Alternate Health Announces Completion of Initial Study to Treat Zika Virus Symptoms with Hemp-Derived Cannabinoids
Alternate Health Announces Completion of Initial Study to Treat Zika Virus Symptoms with Hemp-Derived Cannabinoids.
About this update from Alternate Health Corp
[{"type":"text","content":"\n \n Alternate \n Health Corp. (CSE:AHG, OTC:AHGIF), a diverse healthcare company \n revolutionizing patient care and research through compliance and \n technology in the emerging medical cannabis industry, announced today \n the completion of its initial study to demonstrate the effectiveness of \n cannabinoids in treating chronic post-Zika virus symptoms.\n \n \n The study, conducted at the Neubauer Hyperbaric Neurologic Center, \n evaluated the effectiveness of combining treatment with hyperbaric \n oxygen (HBO) and industrial hemp-derived cannabinoids to alleviate the \n rare but debilitating chronic post-Zika infection symptoms of pain, \n fatigue, anxiety, depressive state, and loss of appetite.\n \n \n The Zika virus is a flavivirus transmitted by mosquitos, and over the \n past 10 years has caused infection in more than 50 countries worldwide. \n Zika has been declared a pandemic and is considered a Public Health \n Emergency by the World Health Organization. The Centers for Disease \n Control and Prevention (CDC) has confirmed there is scientific consensus \n that Zika causes birth defects, and reports have linked its infection to \n an infrequent but serious neurological condition, Guillain-Barré \n Syndrome.\n \n \n Although acute Zika infection is usually self-limiting, some patients \n can experience prolonged periods of severe fatigue, joint pain, loss of \n appetite, anxiety, depressive state, and lethargy after clearance of \n acute viral symptoms. It is these symptoms in this subset of \n Zika-infected patients that Alternate Health evaluated in its initial \n cannabinoid-based, Institutional Review Board (IRB) approved research \n study.\n \n \n All 10 patients enrolled in the study demonstrated a significant \n improvement in their subjective symptoms in less than a month of dual \n therapy with the Alternate Health Corporation’s proprietary hemp-derived \n sub-lingual dissolvable cannabinoid tablet combined with hyperbaric \n oxygen treatments.\n \n \n “The initial results suggesting symptomatic improvement of post-Zika \n infection-related symptoms by combining cannabidiol – a known \n anti-oxidant and anti-inflammatory agent – with hyperbaric oxygen is \n extremely exciting,” said Dr. Jamison Feramisco, CEO, Alternate Health. \n “Although this small study will need ...